About
Technology
Issues
FAQ
Links
Official Page
Multicenter Phase II trial of high‐dose imatinib mesylate in metastatic melanoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.